142 related articles for article (PubMed ID: 9403555)
41. Differential induction of adrenomedullin, interleukins and tumour necrosis factor-alpha by lipopolysaccharide in rat tissues in vivo.
Li YY; Wong LY; Cheung BM; Hwang IS; Tang F
Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1110-8. PubMed ID: 16445578
[TBL] [Abstract][Full Text] [Related]
42. [Upregulation of adrenomedullin system in left ventricular hypertrophy of severe hypertension rats].
Wang X; Toshio N; Li ZZ; Li QX; Zhu XL; Bai SG
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jan; 33(1):77-80. PubMed ID: 15924789
[TBL] [Abstract][Full Text] [Related]
43. Adrenomedullin gene delivery attenuates renal damage and cardiac hypertrophy in Goldblatt hypertensive rats.
Wang C; Dobrzynski E; Chao J; Chao L
Am J Physiol Renal Physiol; 2001 Jun; 280(6):F964-71. PubMed ID: 11352835
[TBL] [Abstract][Full Text] [Related]
44. Increased plasma adrenomedullin levels in chronic congestive heart failure.
Kobayashi K; Kitamura K; Etoh T; Nagatomo Y; Takenaga M; Ishikawa T; Imamura T; Koiwaya Y; Eto T
Am Heart J; 1996 May; 131(5):994-8. PubMed ID: 8615322
[TBL] [Abstract][Full Text] [Related]
45. Glucocorticoid regulation of adrenomedullin in a rat model of endotoxic shock.
Hattori Y; Murakami Y; Atsuta H; Minamino N; Kangawa K; Kasai K
Life Sci; 1998; 62(13):PL181-9. PubMed ID: 9519804
[TBL] [Abstract][Full Text] [Related]
46. Induction of a myocardial adrenomedullin signaling system during ischemic heart failure in rats.
Oie E; Vinge LE; Yndestad A; Sandberg C; Grøgaard HK; Attramadal H
Circulation; 2000 Feb; 101(4):415-22. PubMed ID: 10653834
[TBL] [Abstract][Full Text] [Related]
47. [Levels of adrenomedullin in plasma of patients with chronic congestive heart failure].
Halawa B; Mazurek W
Pol Arch Med Wewn; 1998 Jan; 99(1):2-8. PubMed ID: 9686497
[TBL] [Abstract][Full Text] [Related]
48. Increased plasma adrenomedullin concentrations during cardiac surgery.
Nishikimi T; Hayashi Y; Iribu G; Takishita S; Kosakai Y; Minamino N; Miyata A; Matsuo H; Kuro M; Kangawa K
Clin Sci (Lond); 1998 Jun; 94(6):585-90. PubMed ID: 9854455
[TBL] [Abstract][Full Text] [Related]
49. Regulation of cardiac preload by atrial natriuretic peptide in congestive cardiac failure.
Johnston CI; Hodsman GP; Harrison RW; Mendelsohn FA; Tsunoda K
Am J Med; 1988 Mar; 84(3A):105-11. PubMed ID: 2851266
[TBL] [Abstract][Full Text] [Related]
50. Biosynthesis and secretion of adrenomedullin and proadrenomedullin N-terminal 20 peptide in a rat model of endotoxin shock.
Matsui E; Kitamura K; Yoshida M; Kato J; Asada Y; Sumiyoshi A; Eto T
Hypertens Res; 2001 Sep; 24(5):543-9. PubMed ID: 11675949
[TBL] [Abstract][Full Text] [Related]
51. Increased plasma levels of adrenomedullin, a vasoactive peptide, in patients with end-stage pulmonary disease.
Vizza CD; Letizia C; Sciomer S; Naeije R; Della Rocca G; Di Roma A; Musarò S; Quattrucci S; Gaudio C; Battagliese A; Badagliacca R; D'Erasmo E; Fedele F
Regul Pept; 2005 Jan; 124(1-3):187-93. PubMed ID: 15544858
[TBL] [Abstract][Full Text] [Related]
52. Adrenomedullin as a Biomarker of Heart Failure.
Nishikimi T; Nakagawa Y
Heart Fail Clin; 2018 Jan; 14(1):49-55. PubMed ID: 29153200
[TBL] [Abstract][Full Text] [Related]
53. Adrenomedullin: a possible autocrine or paracrine inhibitor of hypertrophy of cardiomyocytes.
Tsuruda T; Kato J; Kitamura K; Kuwasako K; Imamura T; Koiwaya Y; Tsuji T; Kangawa K; Eto T
Hypertension; 1998 Jan; 31(1 Pt 2):505-10. PubMed ID: 9453353
[TBL] [Abstract][Full Text] [Related]
54. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group.
Richards AM; Doughty R; Nicholls MG; MacMahon S; Sharpe N; Murphy J; Espiner EA; Frampton C; Yandle TG;
J Am Coll Cardiol; 2001 Jun; 37(7):1781-7. PubMed ID: 11401111
[TBL] [Abstract][Full Text] [Related]
55. Beneficial hemodynamic and renal effects of adrenomedullin in an ovine model of heart failure.
Rademaker MT; Charles CJ; Lewis LK; Yandle TG; Cooper GJ; Coy DH; Richards AM; Nicholls MG
Circulation; 1997 Sep; 96(6):1983-90. PubMed ID: 9323090
[TBL] [Abstract][Full Text] [Related]
56. Chronic infusion of adrenomedullin reduces pulmonary hypertension and lessens right ventricular hypertrophy in rats administered monocrotaline.
Yoshihara F; Nishikimi T; Horio T; Yutani C; Takishita S; Matsuo H; Ohe T; Kangawa K
Eur J Pharmacol; 1998 Aug; 355(1):33-9. PubMed ID: 9754936
[TBL] [Abstract][Full Text] [Related]
57. Cardioprotective effect of adrenomedullin in heart failure.
Nishikimi T; Yoshihara F; Mori Y; Kangawa K; Matsuoka H
Hypertens Res; 2003 Feb; 26 Suppl():S121-7. PubMed ID: 12630822
[TBL] [Abstract][Full Text] [Related]
58. Plasma and cardiac tissue atrial and brain natriuretic peptides in experimental heart failure.
Moe GW; Grima EA; Wong NL; Howard RJ; Armstrong PW
J Am Coll Cardiol; 1996 Mar; 27(3):720-7. PubMed ID: 8606288
[TBL] [Abstract][Full Text] [Related]
59. Production and clearance sites of two molecular forms of adrenomedullin in human plasma.
Nishikimi T; Matsuoka H; Shimada K; Matsuo H; Kangawa K
Am J Hypertens; 2000 Sep; 13(9):1032-4. PubMed ID: 10981555
[TBL] [Abstract][Full Text] [Related]
60. Discrepancy between plasma and aortic wall cyclic guanosine monophosphate in an experimental model of congestive heart failure.
Arnal JF; Hofmann F; Michel JB
Cardiovasc Res; 1993 Jun; 27(6):1094-100. PubMed ID: 8221770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
